Page last updated: 2024-09-05

organophosphonates and fosmidomycin

organophosphonates has been researched along with fosmidomycin in 12 studies

Compound Research Comparison

Studies
(organophosphonates)
Trials
(organophosphonates)
Recent Studies (post-2010)
(organophosphonates)
Studies
(fosmidomycin)
Trials
(fosmidomycin)
Recent Studies (post-2010) (fosmidomycin)
9,9688803,59624310116

Protein Interaction Comparison

ProteinTaxonomyorganophosphonates (IC50)fosmidomycin (IC50)
1-deoxy-D-xylulose 5-phosphate reductoisomeraseMycolicibacterium smegmatis MC2 1550.295
1-deoxy-D-xylulose 5-phosphate reductoisomeraseEscherichia coli K-120.0334
1-deoxy-D-xylulose 5-phosphate reductoisomeraseMycobacterium tuberculosis H37Rv0.165
1-deoxy-D-xylulose 5-phosphate reductoisomerase, chloroplasticArabidopsis thaliana (thale cress)0.1
1-deoxy-D-xylulose 5-phosphate reductoisomerase Escherichia coli0.438

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (16.67)29.6817
2010's9 (75.00)24.3611
2020's1 (8.33)2.80

Authors

AuthorsStudies
Bach, TJ; Grosdemange-Billiard, C; Hemmerlin, A; Kuntz, L; Rohmer, M; Tritsch, D; Willem, A1
Giessmann, D; Haemers, T; Heidler, P; Jomaa, H; Link, A; Reichenberg, A; Sanderbrand, S; Van Calenbergh, S; Weidemeyer, C; Wiesner, J1
Grosdemange-Billiard, C; Kuntz, L; Rohmer, M; Tritsch, D; Zinglé, C1
Bae, B; Circello, BT; Kuemin, M; Lee, JH; Metcalf, WW; Nair, SK; van der Donk, WA1
Blatch, GL; Bodill, T; Conibear, AC; Kaye, PT; Lobb, KA1
Andaloussi, M; Björkelid, C; Iyer, H; Karlén, A; Larhed, M; Lindh, M; Suresh, S; Wieckowska, A1
Bae, B; Cobb, RE; DeSieno, MA; Nair, SK; Zhao, H1
Grosdemange-Billiard, C; Ponaire, S; Rohmer, M; Tritsch, D; Zinglé, C1
Bartee, D; Freel Meyers, CL; Harrison, MJ; Koppisch, AT; Phillips, PD; Sanders, S1
Caljon, G; Cos, P; Courtens, C; Martin, A; Risseeuw, M; Van Calenbergh, S1
Eliot, AC; Erb, A; Ju, KS; Metcalf, WW; Parkinson, EI1
Caljon, G; Coenye, T; Cos, P; Courtens, C; Quennesson, T; Risseeuw, M; Van Calenbergh, S; van Charante, F1

Other Studies

12 other study(ies) available for organophosphonates and fosmidomycin

ArticleYear
Isoprenoid biosynthesis as a target for antibacterial and antiparasitic drugs: phosphonohydroxamic acids as inhibitors of deoxyxylulose phosphate reducto-isomerase.
    The Biochemical journal, 2005, Feb-15, Volume: 386, Issue:Pt 1

    Topics: Aldose-Ketose Isomerases; Anti-Bacterial Agents; Antimalarials; Butyrates; Drug Design; Drug Resistance, Multiple, Bacterial; Enzyme Inhibitors; Escherichia coli; Escherichia coli Proteins; Fosfomycin; Hydroxamic Acids; Microbial Sensitivity Tests; Multienzyme Complexes; NADP; Organophosphonates; Oxidoreductases; Terpenes

2005
Towards new antimalarial drugs: synthesis of non-hydrolyzable phosphate mimics as feed for a predictive QSAR study on 1-deoxy-D-xylulose-5-phosphate reductoisomerase inhibitors.
    Chemistry & biodiversity, 2008, Volume: 5, Issue:4

    Topics: Aldose-Ketose Isomerases; Animals; Antimalarials; Drug Design; Enzyme Inhibitors; Escherichia coli; Fosfomycin; Multienzyme Complexes; Organophosphonates; Oxidoreductases; Plasmodium falciparum; Quantitative Structure-Activity Relationship

2008
Isoprenoid biosynthesis via the methylerythritol phosphate pathway: structural variations around phosphonate anchor and spacer of fosmidomycin, a potent inhibitor of deoxyxylulose phosphate reductoisomerase.
    The Journal of organic chemistry, 2010, May-21, Volume: 75, Issue:10

    Topics: Aldose-Ketose Isomerases; Enzyme Inhibitors; Erythritol; Fosfomycin; Molecular Structure; Multienzyme Complexes; Organophosphonates; Oxidoreductases; Structure-Activity Relationship; Sugar Phosphates; Terpenes

2010
Characterization and structure of DhpI, a phosphonate O-methyltransferase involved in dehydrophos biosynthesis.
    Proceedings of the National Academy of Sciences of the United States of America, 2010, Oct-12, Volume: 107, Issue:41

    Topics: Bioengineering; Biosynthetic Pathways; Chromatography, High Pressure Liquid; Chromatography, Ion Exchange; Crystallography, X-Ray; Dipeptides; Esterification; Fosfomycin; Kinetics; Mass Spectrometry; Methylation; Methyltransferases; Molecular Structure; Organophosphonates; S-Adenosylmethionine; Streptomyces; Substrate Specificity

2010
Synthesis and evaluation of phosphonated N-heteroarylcarboxamides as DOXP-reductoisomerase (DXR) inhibitors.
    Bioorganic & medicinal chemistry, 2011, Feb-01, Volume: 19, Issue:3

    Topics: Aldose-Ketose Isomerases; Antimalarials; Computer Simulation; Drug Design; Fosfomycin; Furans; Molecular Structure; Multienzyme Complexes; Organophosphonates; Oxidoreductases; Protein Binding

2011
Substitution of the phosphonic acid and hydroxamic acid functionalities of the DXR inhibitor FR900098: an attempt to improve the activity against Mycobacterium tuberculosis.
    Bioorganic & medicinal chemistry letters, 2011, Sep-15, Volume: 21, Issue:18

    Topics: Aldose-Ketose Isomerases; Antitubercular Agents; Crystallography, X-Ray; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fosfomycin; Hydroxamic Acids; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Multienzyme Complexes; Mycobacterium tuberculosis; Organophosphonates; Oxidoreductases; Stereoisomerism; Structure-Activity Relationship

2011
New N-acetyltransferase fold in the structure and mechanism of the phosphonate biosynthetic enzyme FrbF.
    The Journal of biological chemistry, 2011, Oct-14, Volume: 286, Issue:41

    Topics: Acetyltransferases; Bacterial Proteins; Catalytic Domain; Crystallography, X-Ray; Fosfomycin; Organophosphonates; Protein Folding; Protein Structure, Tertiary; Streptomyces; Structure-Activity Relationship

2011
Growth inhibition of Mycobacterium smegmatis by prodrugs of deoxyxylulose phosphate reducto-isomerase inhibitors, promising anti-mycobacterial agents.
    European journal of medicinal chemistry, 2012, Volume: 51

    Topics: Aldose-Ketose Isomerases; Anti-Bacterial Agents; Enzyme Inhibitors; Fosfomycin; Hydrophobic and Hydrophilic Interactions; Kinetics; Microbial Viability; Multienzyme Complexes; Mycobacterium smegmatis; Organophosphonates; Oxazines; Oxidoreductases; Prodrugs; Xanthenes

2012
Growth medium-dependent antimicrobial activity of early stage MEP pathway inhibitors.
    PloS one, 2018, Volume: 13, Issue:5

    Topics: Aldose-Ketose Isomerases; Anti-Bacterial Agents; Bacillus thuringiensis; Culture Media; Drug Interactions; Enterobacteriaceae; Erythritol; Escherichia coli Proteins; Fosfomycin; Metabolic Networks and Pathways; Microbial Sensitivity Tests; Multienzyme Complexes; Nutrients; Organophosphonates; Terpenes; Transferases

2018
Phosphonodiamidate prodrugs of N-alkoxy analogs of a fosmidomycin surrogate as antimalarial and antitubercular agents.
    Bioorganic & medicinal chemistry letters, 2019, 05-01, Volume: 29, Issue:9

    Topics: Antimalarials; Antitubercular Agents; Cell Line; Cell Survival; Fosfomycin; Humans; Hydroxamic Acids; Mycobacterium tuberculosis; Organophosphonates; Plasmodium falciparum; Prodrugs

2019
Fosmidomycin biosynthesis diverges from related phosphonate natural products.
    Nature chemical biology, 2019, Volume: 15, Issue:11

    Topics: Biological Products; Fosfomycin; Genes, Bacterial; Multigene Family; Organophosphonates; Streptomyces

2019
Acyloxymethyl and alkoxycarbonyloxymethyl prodrugs of a fosmidomycin surrogate as antimalarial and antibacterial agents.
    European journal of medicinal chemistry, 2023, Jan-05, Volume: 245, Issue:Pt 1

    Topics: Anti-Bacterial Agents; Antimalarials; Folic Acid Antagonists; Humans; Malaria, Falciparum; Mycobacterium tuberculosis; Organophosphonates; Prodrugs; Tuberculosis

2023